137 related articles for article (PubMed ID: 38000294)
1. Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline.
Krah A; Ragunathan P; Bond PJ; Grüber G
Biochem Biophys Res Commun; 2024 Jan; 690():149249. PubMed ID: 38000294
[TBL] [Abstract][Full Text] [Related]
2. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
3. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
[TBL] [Abstract][Full Text] [Related]
4. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
Salifu EY; Agoni C; Olotu FA; Soliman MES
Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
[TBL] [Abstract][Full Text] [Related]
5. TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
Sarathy JP; Ganapathy US; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964791
[TBL] [Abstract][Full Text] [Related]
6. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
7.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
8. Anti-Mycobacterium abscessus Activity of Tuberculosis F-ATP Synthase Inhibitor GaMF1.
Ragunathan P; Dick T; Grüber G
Antimicrob Agents Chemother; 2022 May; 66(5):e0001822. PubMed ID: 35481752
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of mycobacterial ATP synthase inhibition by squaramides and second generation diarylquinolines.
Courbon GM; Palme PR; Mann L; Richter A; Imming P; Rubinstein JL
EMBO J; 2023 Aug; 42(15):e113687. PubMed ID: 37377118
[TBL] [Abstract][Full Text] [Related]
10. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
[TBL] [Abstract][Full Text] [Related]
11.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
12. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
Gutiérrez AV; Richard M; Roquet-Banères F; Viljoen A; Kremer L
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332077
[No Abstract] [Full Text] [Related]
13. Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in
Martin A; Bouyakoub Y; Soumillion K; Mantu EON; Colmant A; Rodriguez-Villalobos H
Int J Mycobacteriol; 2020; 9(1):71-75. PubMed ID: 32474492
[TBL] [Abstract][Full Text] [Related]
14. Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase.
Krah A; Grüber G; Bond PJ
Curr Res Struct Biol; 2022; 4():278-284. PubMed ID: 36186842
[TBL] [Abstract][Full Text] [Related]
15. Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline.
Guo H; Courbon GM; Bueler SA; Mai J; Liu J; Rubinstein JL
Nature; 2021 Jan; 589(7840):143-147. PubMed ID: 33299175
[TBL] [Abstract][Full Text] [Related]
16.
Schulthess B; Akdoğan Kittana FN; Hömke R; Sander P
Antimicrob Agents Chemother; 2022 May; 66(5):e0234621. PubMed ID: 35420492
[TBL] [Abstract][Full Text] [Related]
17. TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.
Sarathy JP; Ragunathan P; Cooper CB; Upton AM; Grüber G; Dick T
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712198
[TBL] [Abstract][Full Text] [Related]
18.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
19. Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of
Wang Z; Soni V; Marriner G; Kaneko T; Boshoff HIM; Barry CE; Rhee KY
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19646-19651. PubMed ID: 31501323
[TBL] [Abstract][Full Text] [Related]
20. Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus.
Lindman M; Dick T
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
